Numerous genetic and epigenetic alterations are involved in the development and progression of NSCLC, comprising mutations in key genes such as epidermal growth factor receptor (EGFR), ALK tyrosine kinase receptor (ALK), and Kirsten rat sarcoma viral oncogene homolog (KRAS) [4]. Here, KRAS is linked to non-small cell lung carcinoma.